Leadership and Shareholders
Meet the people and organizations supporting Glycotest’s mission to transform liver cancer outcomes through earlier detection.
Management Team and Board
Our management team and Board combine scientific, operational, legal and investment experience supporting the development and commercialization of Glycotest’s diagnostic platform.

Charles Swindell
Charles Swindell has over 30 years of experience in biopharmaceutical R&D, product development, and senior management in entrepreneurial life science companies. He has been head of R&D at two…
Read full biography →
Dr Ilian Iliev
Ilian founded EMV Capital in 2018. Following its acquisition by EMV Capital PLC (then NetScientific), he became Group Chief Executive Officer. Previously, he co-founded and served as Chief Executive…
Read full biography →
Ed Hooper
Ed Hooper is Executive Director, General Counsel and Group Company Secretary of EMV Capital, where he provides legal, strategic and commercial support to the Group and its portfolio…
Read full biography →
Ms Pei Jiang
Ms. Pei JIANG graduated with Master degree of lmmunology from Fudan University in 2012. She joined Shanghai Fosun Long March Medical Science Co., Ltd since July 2012 till…
Read full biography →Scientific and Medical Advisors
Our Scientific and Medical Advisors bring internationally recognized expertise across hepatology, glycobiology, clinical diagnostics and translational medicine. Their knowledge supports the continued development, clinical validation and future commercialization of Glycotest’s diagnostic platform.

Timothy Block, PhD
Dr. Block is Co-Founder and President of the Baruch S. Blumberg Institute and the Hepatitis B Foundation, which established the Institute in 2003 to advance its research mission…
Read full biography →
Anand Mehta, DPhil
Dr. Mehta is SmartState Endowed Chair of Proteomic Biomarkers and Professor, Medical University of South Carolina. He received his graduate degree in Biochemistry from the University of Oxford…
Read full biography →
David Chernoff, MD
Dr. Chernoff has served as acting Chief Medical Officer for several start-up molecular diagnostic companies including XDx, CardioDx, and Tethys Bioscience. Previously, he was Vice President of Corporate…
Read full biography →
Scott Friedman, MD
Scott Friedman is Chief of the Division of Liver Diseases and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai, New York and was…
Read full biography →
Douglas Dieterich, MD
Douglas Dieterich is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, New York with appointments in the Divisions of Liver Diseases, Gastroenterology and Infectious…
Read full biography →



